| Name | tert-butyl 4,4-dimethyl-5H-imidazo[1,5-a]quinoxaline-3-carboxylate |
|---|---|
| Synonyms |
U 93631, GABAA antagonist
U93631 U93631, 10 mM in DMSO tert-butyl 4,4-dimethyl-4H,5H-imidazo[1,5-a]quinoxaline-3-cboxylate tert-butyl 4,4-dimethyl-5H-imidazo[1,5-a]quinoxaline-3-cboxylate U-93631; U Imidazo(1,5-a)quinoxaline-3-cboxylic acid, 4,5-dihydro-4,4-dimethyl-, 1,1-dimethylethyl ester Inhibitor,γ-Aminobutyric acid Rector,U 93631,U93631,inhibit,Gamma-aminobutyric acid Rector,GABA Rector,U-93631 tert-Butyl 4,4-dimethyl-4,5-dihydroimidazo[1,5-a]quinoxaline-3-cboxylate 4,5-Dihydro-4,4-dimethyl-imidazo[1,5-a]quinoxaline-3-cboxylicacid1,1-dimethylethylester |
| Description | U93631 is a GABAA receptor ligand of novel chemical structure with IC50 of 100 nM,and has been shown to induce a rapid, time-dependent decay of GABA-induced whole-cell Cl-currents in recombinant GABAA receptors. target: GABAA receptorIC 50: GABAA receptor[1]In vitro: In the presence of U93631 at 5 UM, the peak amplitude decreased as a function of GABA concentration, with the half-maximal inhibitory concentration being approximately 100 nM, which is close to the Kd for the high affinity GABA site(85 nM). It appears that the drug interacts with GABA-bound receptors (at least monoliganded) and accelerates receptor desensitization,rather than acting as an open channel blocker. [1] |
|---|---|
| Related Catalog | |
| References |
| Density | 1.19g/cm3 |
|---|---|
| Boiling Point | 470.1ºC at 760 mmHg |
| Molecular Formula | C17H21N3O2 |
| Molecular Weight | 299.36800 |
| Flash Point | 238.1ºC |
| Exact Mass | 299.16300 |
| PSA | 56.15000 |
| LogP | 3.62620 |
| Vapour Pressure | 5.2E-09mmHg at 25°C |
| Index of Refraction | 1.598 |
| Storage condition | 2-8℃ |